Editas Medicine Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (41)

Latest Posts

About This Stock More About This Stock
TA For 7 US Stocks: DE, DOCU, EDIT, ESLT, EVGN, FARO, FATE
Video By: Peter Mathers
Sunday, September 6, 2020 7:30 PM EDT
Price technical analysis, Elliott Wave and trading levels for Deere, Docusign, Editas, Elbit Systems, Evogene, Faro Technologies and Fate Therapeutics
In this video: DE, FARO, ESLT, EVGN, FATE, EDIT, DOCU
Watch
Wall Street's Top Stories For Christmas Weekend
Article By: The Fly
Sunday, December 23, 2018 3:55 PM EDT
Stocks end week on down note amid concerns of government shutdown and company updates on Nike, Altira, Perrigo, JD, NetEase, Air Transport Service, Amazon, Editas Medicine and CalAmp.
In this article: JD, MO, NKE, AMZN, ATSG, CAMP, NTES, PRGO, EDIT
Read
CRISPR Stocks Rise After Chinese Researcher Claims First Gene-Edited Babies
Article By: The Fly
Monday, November 26, 2018 1:47 PM EDT
Shares of Crispr Therapeutics, Editas Medicine and Intellia Therapeutics are on the rise after a Chinese researcher claimed that he helped make the world's first genetically edited babies.
In this article: CRSP, EDIT, NTLA Also: SGMO
Read
Winners Of Q1 Earnings: 5 Best ETF Charts
Article By: Sweta Killa
Sunday, May 27, 2018 4:01 PM EDT
several equity ETFs have impressed with their performances and generated handsome returns over the trailing one month even after being hit by the trade worries and geopolitical tensions. Here are five ETFs that buoyed up on robust earnings results.
In this article: PTH, SPY, PSCE, GAMR, ARKK, ILMN, SSYS, TSLA, EDIT, NTLA, MKSI, FTXL
Read
Three ‘Strong Buy’ Biotechs To Tap Now
Article By: TipRanks
Wednesday, May 16, 2018 9:58 AM EDT
Which biotechs are paving the way to precisely repair the genes in the DNA?
In this article: VRTX, EDIT, CRSP
Read

PARTNER HEADLINES

Latest Tweets for $EDIT

No tweets yet!

$EDIT

Editas Medicine, Inc., Announces Pricing Of $50 Million Offering Of Common Stock
Michael Molman 12/6/2017 5:41:11 PM

Looking forward to hearing more information about $EDIT. Company seems to operate in a very exiting and potentially fast growing new field.

1 to 1 of 1 comments